Details of the Drug Combination

General Information of Drug Combination (ID: DCSQ37Q)

Drug Combination Name
Repaglinide Rosiglitazone
Indication
Disease Entry Status REF
Diabetes Mellitus, Type 2 Phase 1 [1]
Component Drugs Repaglinide   DM5SXUV Rosiglitazone   DMILWZR
Small molecular drug N.A.

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Repaglinide
Disease Entry ICD 11 Status REF
Diabetic complication 5A2Y Approved [2]
Repaglinide Interacts with 2 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
ATP-binding cassette transporter C9 (ABCC9) TTEF5MJ ABCC9_HUMAN Blocker [3]
ATP-binding cassette transporter C8 (ABCC8) TTP835K ABCC8_HUMAN Blocker [3]
------------------------------------------------------------------------------------
Repaglinide Interacts with 1 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Organic anion transporting polypeptide 1B1 (SLCO1B1) DT3D8F0 SO1B1_HUMAN Substrate [4]
------------------------------------------------------------------------------------
Repaglinide Interacts with 3 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Metabolism [5]
UDP-glucuronosyltransferase 1A1 (UGT1A1) DEYGVN4 UD11_HUMAN Metabolism [6]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Metabolism [5]
------------------------------------------------------------------------------------
Repaglinide Interacts with 5 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Solute carrier organic anion transporter family member 1B1 (SLCO1B1) OTNEN8QK SO1B1_HUMAN Affects Metabolism [7]
Bile salt export pump (ABCB11) OTRU7THO ABCBB_HUMAN Decreases Activity [8]
Interleukin-8 (CXCL8) OTS7T5VH IL8_HUMAN Decreases Expression [9]
HLA class I histocompatibility antigen, alpha chain F (HLA-F) OT76CM19 HLAF_HUMAN Affects Expression [10]
Major histocompatibility complex class I-related gene protein (MR1) OTZU3XX7 HMR1_HUMAN Affects Expression [10]
------------------------------------------------------------------------------------
Indication(s) of Rosiglitazone
Disease Entry ICD 11 Status REF
Chronic kidney disease GB61 Terminated []
Rosiglitazone Interacts with 1 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [18]
------------------------------------------------------------------------------------
Rosiglitazone Interacts with 4 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Metabolism [19]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Metabolism [20]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Metabolism [20]
Prostaglandin G/H synthase 1 (COX-1) DE073H6 PGH1_HUMAN Metabolism [21]
------------------------------------------------------------------------------------
Rosiglitazone Interacts with 388 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2) OTW8V2V1 ABCG2_HUMAN Increases Expression [22]
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (HSD3B2) OT02MSKN 3BHS2_HUMAN Decreases Activity [23]
Acetyl-CoA acetyltransferase, mitochondrial (ACAT1) OTJC60Q7 THIL_HUMAN Decreases Expression [24]
Perilipin-2 (PLIN2) OTRXJ9UN PLIN2_HUMAN Increases Expression [24]
Choriogonadotropin subunit beta 3 (CGB3) OTVM2SU3 CGB3_HUMAN Increases Expression [25]
Phospholipid-transporting ATPase ABCA1 (ABCA1) OT94G6BQ ABCA1_HUMAN Increases Expression [26]
Golgin subfamily A member 8A (GOLGA8A) OTSNE9EQ GOG8A_HUMAN Decreases Expression [11]
CMRF35-like molecule 7 (CD300LB) OTVC407Y CLM7_HUMAN Increases Expression [11]
Signal-regulatory protein beta-1 (SIRPB1) OTGHALWJ SIRB1_HUMAN Increases Expression [11]
Regulatory factor X-associated protein (RFXAP) OTX46DKQ RFXAP_HUMAN Decreases Expression [11]
Agrin (AGRN) OTWJENAZ AGRIN_HUMAN Decreases Expression [11]
Phospholipid phosphatase 3 (PLPP3) OTSSF7BK PLPP3_HUMAN Increases Expression [11]
Low-density lipoprotein receptor class A domain-containing protein 4 (LDLRAD4) OTQUX50Z LRAD4_HUMAN Increases Expression [11]
Tumor necrosis factor ligand superfamily member 12 (TNFSF12) OT6FQ02V TNF12_HUMAN Decreases Expression [11]
Leukocyte immunoglobulin-like receptor subfamily A member 1 (LILRA1) OTZ4NA7Q LIRA1_HUMAN Increases Expression [11]
Rho-related BTB domain-containing protein 3 (RHOBTB3) OT1BFKPH RHBT3_HUMAN Increases Expression [11]
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2) OTDLEXPN PAPS2_HUMAN Increases Expression [11]
Mitogen-activated protein kinase kinase kinase 6 (MAP3K6) OTOE0Z1R M3K6_HUMAN Decreases Expression [11]
BAG family molecular chaperone regulator 2 (BAG2) OTI6LD27 BAG2_HUMAN Increases Expression [11]
Retinol-binding protein 1 (RBP1) OTRP1MFC RET1_HUMAN Increases Expression [11]
Peroxisomal coenzyme A diphosphatase NUDT7 (NUDT7) OTCPOQ6W NUDT7_HUMAN Decreases Expression [11]
Antigen-presenting glycoprotein CD1d (CD1D) OT3ROU4J CD1D_HUMAN Increases Expression [11]
Protein-glutamine gamma-glutamyltransferase 2 (TGM2) OT6MFOWF TGM2_HUMAN Increases Expression [11]
Collagen alpha-3(V) chain (COL5A3) OTCGC4DM CO5A3_HUMAN Increases Expression [11]
Rap1 GTPase-activating protein 1 (RAP1GAP) OTC31ONQ RPGP1_HUMAN Decreases Expression [11]
Nuclear receptor-interacting protein 1 (NRIP1) OTIZOJQV NRIP1_HUMAN Increases Expression [11]
Ribose-5-phosphate isomerase (RPIA) OT805SMH RPIA_HUMAN Increases Expression [11]
Thrombospondin-3 (THBS3) OTDKMUBD TSP3_HUMAN Increases Expression [11]
PDZ and LIM domain protein 4 (PDLIM4) OT23LZYY PDLI4_HUMAN Decreases Expression [11]
Histone H2B type 1-D (H2BC5) OTXDTDHN H2B1D_HUMAN Decreases Expression [11]
Ras-related protein Rab-15 (RAB15) OTU0GGR3 RAB15_HUMAN Decreases Expression [11]
Oxidized low-density lipoprotein receptor 1 (OLR1) OTS44RIC OLR1_HUMAN Increases Expression [11]
Amyloid beta precursor like protein 2 (APLP2) OTTFE53M APLP2_HUMAN Increases Expression [11]
Myotonin-protein kinase (DMPK) OT9XJKG4 DMPK_HUMAN Decreases Expression [11]
Dystrophia myotonica WD repeat-containing protein (DMWD) OT0CBZ6F DMWD_HUMAN Decreases Expression [11]
Alpha-(1,3)-fucosyltransferase 7 (FUT7) OTJF6BSN FUT7_HUMAN Decreases Expression [11]
H2.0-like homeobox protein (HLX) OT7DTH46 HLX_HUMAN Decreases Expression [11]
Uncharacterized protein KIAA0040 (KIAA0040) OT27EBY3 K0040_HUMAN Decreases Expression [11]
Nicotinate-nucleotide pyrophosphorylase (QPRT) OT6SKKLL NADC_HUMAN Decreases Expression [11]
Zinc finger protein SNAI3 (SNAI3) OTG9DI66 SNAI3_HUMAN Increases Expression [11]
Pleckstrin homology-like domain family A member 2 (PHLDA2) OTMV9DPP PHLA2_HUMAN Decreases Expression [11]
Late cornified envelope-like proline-rich protein 1 (LELP1) OTOQIVV0 LELP1_HUMAN Decreases Expression [11]
Protein sel-1 homolog 3 (SEL1L3) OT10N6Z2 SE1L3_HUMAN Increases Expression [11]
Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) OTXIGC6I LAIR1_HUMAN Increases Expression [11]
Myogenesis-regulating glycosidase (MYORG) OTVK4VMH MYORG_HUMAN Decreases Expression [11]
Uncharacterized protein C16orf46 (C16ORF46) OT8FDG3A CP046_HUMAN Decreases Expression [11]
Phospholipase B-like 1 (PLBD1) OTHYEB4W PLBL1_HUMAN Increases Expression [11]
Low-density lipoprotein receptor-related protein 11 (LRP11) OTQNI7L8 LRP11_HUMAN Decreases Expression [11]
Sodium-independent sulfate anion transporter (SLC26A11) OTWBV9CR S2611_HUMAN Increases Expression [11]
Cerebellar degeneration-related protein 2-like (CDR2L) OT5UVB1J CDR2L_HUMAN Decreases Expression [11]
SLIT and NTRK-like protein 4 (SLITRK4) OTSCN5AM SLIK4_HUMAN Increases Expression [11]
Retinol dehydrogenase 10 (RDH10) OTL9FSGF RDH10_HUMAN Increases Expression [11]
Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1L) OTVLWW9T GPD1L_HUMAN Decreases Expression [11]
Sesquipedalian-1 (PHETA1) OT4IMC0X SESQ1_HUMAN Decreases Expression [11]
Refilin-B (RFLNB) OTI7ZM75 RFLB_HUMAN Increases Expression [11]
Uncharacterized protein FAM241A (FAM241A) OTC12ETA F241A_HUMAN Decreases Expression [11]
F-box only protein 15 (FBXO15) OTJHEFE5 FBX15_HUMAN Increases Expression [11]
CMRF35-like molecule 1 (CD300LF) OTQWJGSR CLM1_HUMAN Increases Expression [11]
Serine-rich single-pass membrane protein 1 (SSMEM1) OTH78CH0 SSMM1_HUMAN Decreases Expression [11]
Interactor protein for cytohesin exchange factors 1 (IPCEF1) OTOUIHID ICEF1_HUMAN Decreases Expression [11]
Cortactin-binding protein 2 (CTTNBP2) OT4CL1EW CTTB2_HUMAN Decreases Expression [11]
Mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1) OT6FQ1K3 M4K1_HUMAN Decreases Expression [11]
Kinesin-like protein KIFC2 (KIFC2) OTLTVM7V KIFC2_HUMAN Decreases Expression [11]
Metalloendopeptidase OMA1, mitochondrial (OMA1) OT0JRVY7 OMA1_HUMAN Increases Expression [11]
PDZ and LIM domain protein 2 (PDLIM2) OTEURRPD PDLI2_HUMAN Decreases Expression [11]
Fatty acyl-CoA reductase 2 (FAR2) OTRYY709 FACR2_HUMAN Increases Expression [11]
PML-RARA-regulated adapter molecule 1 (PRAM1) OTZN3DWD PRAM_HUMAN Increases Expression [11]
Dehydrogenase/reductase SDR family member 9 (DHRS9) OTB1WOZA DHRS9_HUMAN Increases Expression [11]
Caspase recruitment domain-containing protein 14 (CARD14) OTADQHOV CAR14_HUMAN Increases Expression [11]
TBC1 domain family member 2A (TBC1D2) OTSGHPD0 TBD2A_HUMAN Increases Expression [11]
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4 (B3GNT4) OTRKV2N8 B3GN4_HUMAN Increases Expression [11]
Gamma-aminobutyric acid receptor-associated protein-like 1 (GABARAPL1) OT4U7SBG GBRL1_HUMAN Increases Expression [11]
Dendritic cell-specific transmembrane protein (DCSTAMP) OTFKRP2H DCSTP_HUMAN Increases Expression [11]
Ribokinase (RBKS) OTDG01Y9 RBSK_HUMAN Increases Expression [11]
Tensin-1 (TNS1) OTZ8S1PL TENS1_HUMAN Decreases Expression [11]
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC (MAN1C1) OT44TM7D MA1C1_HUMAN Decreases Expression [11]
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (AGPAT4) OT5CTQKO PLCD_HUMAN Increases Expression [11]
Ras-related protein Rab-20 (RAB20) OTP9OOVS RAB20_HUMAN Increases Expression [11]
ETS homologous factor (EHF) OTY6TPWD EHF_HUMAN Increases Expression [11]
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (MGAT4C) OTQ2R629 MGT4C_HUMAN Decreases Expression [11]
DnaJ homolog subfamily C member 5B (DNAJC5B) OTHDMM7O DNJ5B_HUMAN Increases Expression [11]
Meteorin (METRN) OTI2645G METRN_HUMAN Decreases Expression [11]
Adherens junction-associated protein 1 (AJAP1) OTAAW121 AJAP1_HUMAN Increases Expression [11]
Paladin (PALD1) OTLGUM8H PALD_HUMAN Decreases Expression [11]
Protein NDRG2 (NDRG2) OT5L6KD7 NDRG2_HUMAN Decreases Expression [11]
Phosphatidylinositide phosphatase SAC2 (INPP5F) OTPKUY50 SAC2_HUMAN Increases Expression [11]
Transducin beta-like protein 2 (TBL2) OTCIMSK8 TBL2_HUMAN Increases Expression [11]
Transmembrane protein 14A (TMEM14A) OTANQA6G TM14A_HUMAN Decreases Expression [11]
Collagen alpha-1(I) chain (COL1A1) OTI31178 CO1A1_HUMAN Increases Expression [27]
C-C motif chemokine 3 (CCL3) OTW2H3ND CCL3_HUMAN Decreases Expression [27]
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1) OTA675TJ GTR1_HUMAN Decreases Expression [27]
Lipid transferase CIDEC (CIDEC) OTMDZ56K CIDEC_HUMAN Increases Expression [27]
Resistin (RETN) OTW5Z1NH RETN_HUMAN Decreases Expression [27]
Proline dehydrogenase 1, mitochondrial (PRODH) OT7SQ1C7 PROD_HUMAN Increases Expression [28]
Transcription factor p65 (RELA) OTUJP9CN TF65_HUMAN Decreases Expression [29]
Bile salt export pump (ABCB11) OTRU7THO ABCBB_HUMAN Decreases Activity [30]
Cytochrome c oxidase subunit 1 (COX1) OTG3O9BN COX1_HUMAN Increases Expression [31]
Succinate dehydrogenase flavoprotein subunit, mitochondrial (SDHA) OTOJ8QFF SDHA_HUMAN Increases Expression [31]
Transcription factor A, mitochondrial (TFAM) OTXXV5V7 TFAM_HUMAN Increases Expression [31]
Fucose mutarotase (FUOM) OTM201HH FUCM_HUMAN Decreases Expression [12]
Myotubularin-related protein 11 (MTMR11) OTHL2O08 MTMRB_HUMAN Decreases Expression [12]
Aspartate dehydrogenase domain-containing protein (ASPDH) OTN38YBY ASPDH_HUMAN Decreases Expression [12]
D-dopachrome decarboxylase-like protein (DDTL) OTG1LU87 DDTL_HUMAN Decreases Expression [12]
Espin (ESPN) OT7Z6LX2 ESPN_HUMAN Decreases Expression [12]
Sodium/nucleoside cotransporter 1 (SLC28A1) OTXWVV9O S28A1_HUMAN Decreases Expression [12]
Matrilin-2 (MATN2) OTVDR68G MATN2_HUMAN Decreases Expression [12]
Kynurenine 3-monooxygenase (KMO) OT3MRMM9 KMO_HUMAN Decreases Expression [12]
Solute carrier family 22 member 1 (SLC22A1) OT7817I4 S22A1_HUMAN Decreases Expression [12]
Calpain-5 (CAPN5) OTQ8QM7K CAN5_HUMAN Decreases Expression [12]
Insulin-induced gene 1 protein (INSIG1) OTZF5X1D INSI1_HUMAN Decreases Expression [12]
Protein MTSS 1 (MTSS1) OT5DTDO2 MTSS1_HUMAN Decreases Expression [12]
Synaptotagmin-7 (SYT7) OTBWAOWY SYT7_HUMAN Decreases Expression [12]
Glucose-6-phosphate exchanger SLC37A4 (SLC37A4) OTLCYA32 G6PT1_HUMAN Decreases Expression [12]
Perilipin-1 (PLIN1) OT3OAAZ4 PLIN1_HUMAN Increases Expression [12]
Peroxisomal membrane protein 11A (PEX11A) OT8MJ9CJ PX11A_HUMAN Increases Expression [12]
Tumor necrosis factor receptor superfamily member 21 (TNFRSF21) OT3EDGXO TNR21_HUMAN Increases Expression [12]
Lathosterol oxidase (SC5D) OT41KMW4 SC5D_HUMAN Decreases Expression [12]
Organic cation/carnitine transporter 2 (SLC22A5) OTC36TYB S22A5_HUMAN Increases Expression [12]
ABC-type organic anion transporter ABCA8 (ABCA8) OTCWLX6N ABCA8_HUMAN Decreases Expression [12]
ATP-binding cassette sub-family C member 6 (ABCC6) OTZT0LKT MRP6_HUMAN Decreases Expression [12]
Ornithine transcarbamylase, mitochondrial (OTC) OTJ57GGA OTC_HUMAN Decreases Expression [12]
Serine protease inhibitor Kazal-type 1 (SPINK1) OTSUVAL2 ISK1_HUMAN Increases Expression [12]
HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) OT7KZMP2 DRA_HUMAN Decreases Expression [12]
Glycophorin-C (GYPC) OTOEDR7O GLPC_HUMAN Increases Expression [12]
Fructose-bisphosphate aldolase B (ALDOB) OT7FR69A ALDOB_HUMAN Decreases Expression [12]
Tyrosine-protein kinase Fyn (FYN) OTLSLVZS FYN_HUMAN Decreases Expression [12]
Asialoglycoprotein receptor 2 (ASGR2) OTFSGOVY ASGR2_HUMAN Decreases Expression [12]
Complement component C8 alpha chain (C8A) OTIJ65J4 CO8A_HUMAN Decreases Expression [12]
Complement component C8 beta chain (C8B) OTGDJJOK CO8B_HUMAN Decreases Expression [12]
Complement component C8 gamma chain (C8G) OTZM027I CO8G_HUMAN Decreases Expression [12]
All-trans-retinol dehydrogenase ADH4 (ADH4) OTKDKKNG ADH4_HUMAN Decreases Expression [12]
Nucleoprotein TPR (TPR) OTUBBA4W TPR_HUMAN Decreases Expression [12]
5-aminolevulinate synthase, non-specific, mitochondrial (ALAS1) OTQY6ZSF HEM1_HUMAN Increases Expression [12]
Beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1) OT7US3NO SIAT1_HUMAN Decreases Expression [12]
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (PFKFB1) OTTHX4NB F261_HUMAN Decreases Expression [12]
5'-nucleotidase (NT5E) OT7J5LT6 5NTD_HUMAN Decreases Expression [12]
Sterol carrier protein 2 (SCP2) OTPAFCPQ SCP2_HUMAN Decreases Expression [12]
Arylacetamide deacetylase (AADAC) OT8VACT2 AAAD_HUMAN Increases Expression [12]
Vitamin K-dependent protein Z (PROZ) OTI3TXBE PROZ_HUMAN Decreases Expression [12]
Receptor-type tyrosine-protein phosphatase epsilon (PTPRE) OTOD5NID PTPRE_HUMAN Increases Expression [12]
Plasma membrane calcium-transporting ATPase 4 (ATP2B4) OTMWFDAC AT2B4_HUMAN Increases Expression [12]
G0/G1 switch protein 2 (G0S2) OT8FL49L G0S2_HUMAN Decreases Expression [12]
Alcohol dehydrogenase 6 (ADH6) OTS7DYH9 ADH6_HUMAN Decreases Expression [12]
CCN family member 2 (CCN2) OTC39NSU CCN2_HUMAN Decreases Expression [12]
Kallistatin (SERPINA4) OTBK0GG7 KAIN_HUMAN Decreases Expression [12]
D-dopachrome decarboxylase (DDT) OTF5HTYL DOPD_HUMAN Decreases Expression [12]
GTP cyclohydrolase 1 feedback regulatory protein (GCHFR) OTEOT8GI GFRP_HUMAN Decreases Expression [12]
Carbamoyl-phosphate synthase , mitochondrial (CPS1) OTXV8NSR CPSM_HUMAN Decreases Expression [12]
CD70 antigen (CD70) OTHB2AL1 CD70_HUMAN Increases Expression [12]
Carbonic anhydrase 5A, mitochondrial (CA5A) OTP9M7VW CAH5A_HUMAN Decreases Expression [12]
Glucose-6-phosphatase catalytic subunit 1 (G6PC1) OTJ6FM9F G6PC1_HUMAN Decreases Expression [12]
Isoleucine--tRNA ligase, cytoplasmic (IARS1) OT9WXH5N SYIC_HUMAN Increases Expression [12]
Afamin (AFM) OTPOR8IO AFAM_HUMAN Decreases Expression [12]
5-hydroxytryptamine receptor 3A (HTR3A) OTAIV1AK 5HT3A_HUMAN Increases Expression [12]
Flavin-containing monooxygenase 5 (FMO5) OTTILF8T FMO5_HUMAN Decreases Expression [12]
Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A) OTI862QH CPT1A_HUMAN Increases Expression [12]
Aldehyde dehydrogenase family 3 member A2 (ALDH3A2) OT714BUO AL3A2_HUMAN Increases Expression [12]
Trifunctional enzyme subunit beta, mitochondrial (HADHB) OT4Y1I62 ECHB_HUMAN Increases Expression [12]
Inhibin beta E chain (INHBE) OTOI2NYG INHBE_HUMAN Decreases Expression [12]
Protein BTG1 (BTG1) OTVJ2CDM BTG1_HUMAN Decreases Expression [12]
T-complex protein 1 subunit beta (CCT2) OTW1VV4E TCPB_HUMAN Increases Expression [12]
Sushi repeat-containing protein SRPX (SRPX) OT5B9LXS SRPX_HUMAN Increases Expression [12]
4-aminobutyrate aminotransferase, mitochondrial (ABAT) OTXAGR7J GABT_HUMAN Decreases Expression [12]
Cytochrome c oxidase subunit 6A2, mitochondrial (COX6A2) OTQR5SXD CX6A2_HUMAN Decreases Expression [12]
Aminoacylase-1 (ACY1) OT9WU7X3 ACY1_HUMAN Decreases Expression [12]
Transcription factor SOX-4 (SOX4) OTSS40SS SOX4_HUMAN Increases Expression [12]
Follistatin-related protein 1 (FSTL1) OT6KEZUD FSTL1_HUMAN Increases Expression [12]
Secreted phosphoprotein 24 (SPP2) OTX254AR SPP24_HUMAN Decreases Expression [12]
Syntaxin-3 (STX3) OT4CIWLJ STX3_HUMAN Increases Expression [12]
Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) OTGTAGCV PPR1A_HUMAN Decreases Expression [12]
Dihydropyrimidinase (DPYS) OTLTUIVL DPYS_HUMAN Decreases Expression [12]
SPARC-like protein 1 (SPARCL1) OT74DWMV SPRL1_HUMAN Decreases Expression [12]
Laminin subunit alpha-4 (LAMA4) OTHI7TA0 LAMA4_HUMAN Increases Expression [12]
Hydroxyacylglutathione hydrolase, mitochondrial (HAGH) OTYMDAYV GLO2_HUMAN Decreases Expression [12]
Phosphoenolpyruvate carboxykinase , mitochondrial (PCK2) OTJ8LX4N PCKGM_HUMAN Decreases Expression [12]
BTB/POZ domain-containing protein 16 (BTBD16) OT04G9HG BTBDG_HUMAN Decreases Expression [12]
Ectonucleoside triphosphate diphosphohydrolase 8 (ENTPD8) OTB9GJ1V ENTP8_HUMAN Decreases Expression [12]
Kidney mitochondrial carrier protein 1 (SLC25A30) OT2VA5PI KMCP1_HUMAN Increases Expression [12]
Early estrogen-induced gene 1 protein (EEIG1) OT2BMEAE EEIG1_HUMAN Increases Expression [12]
Solute carrier family 22 member 10 (SLC22A10) OTUVJI3H S22AA_HUMAN Decreases Expression [12]
Acyl-coenzyme A synthetase ACSM5, mitochondrial (ACSM5) OTWMDQPX ACSM5_HUMAN Decreases Expression [12]
Iodotyrosine deiodinase 1 (IYD) OT8BQWTE IYD1_HUMAN Decreases Expression [12]
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (LINGO4) OTLADERJ LIGO4_HUMAN Decreases Expression [12]
Alkylglycerol monooxygenase (AGMO) OTGMAHAT ALKMO_HUMAN Decreases Expression [12]
Ras and Rab interactor-like protein (RINL) OTZ0NDKE RINL_HUMAN Increases Expression [12]
Hemojuvelin (HJV) OT4235J2 RGMC_HUMAN Decreases Expression [12]
Mitochondrial S-adenosylmethionine carrier protein (SLC25A26) OTSF2NXD SAMC_HUMAN Increases Expression [12]
Equilibrative nucleoside transporter 4 (SLC29A4) OTWTZXMX S29A4_HUMAN Increases Expression [12]
Transient receptor potential cation channel subfamily M member 8 (TRPM8) OT7ACGYK TRPM8_HUMAN Increases Expression [12]
L-xylulose reductase (DCXR) OTYVXRXB DCXR_HUMAN Decreases Expression [12]
Organic solute transporter subunit alpha (SLC51A) OTDJRZ0P OSTA_HUMAN Decreases Expression [12]
Organic solute transporter subunit beta (SLC51B) OT4WYPSR OSTB_HUMAN Increases Expression [12]
2-acylglycerol O-acyltransferase 3 (MOGAT3) OTPGLUBS MOGT3_HUMAN Decreases Expression [12]
Src kinase-associated phosphoprotein 1 (SKAP1) OTD4ZKAL SKAP1_HUMAN Decreases Expression [12]
Cell division cycle protein 20 homolog B (CDC20B) OTO5F8CF CD20B_HUMAN Decreases Expression [12]
Organic anion transporter 7 (SLC22A9) OTO4BJCC S22A9_HUMAN Decreases Expression [12]
Volume-regulated anion channel subunit LRRC8A (LRRC8A) OT23OE7H LRC8A_HUMAN Decreases Expression [12]
Tumor protein p53-inducible nuclear protein 2 (TP53INP2) OT0GTBXO T53I2_HUMAN Decreases Expression [12]
Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 (PPIL6) OTOZQMQE PPIL6_HUMAN Increases Expression [12]
NADH dehydrogenase 1 alpha subcomplex assembly factor 2 (NDUFAF2) OTC8QPRS NDUF2_HUMAN Increases Expression [12]
Lysoplasmalogenase TMEM86B (TMEM86B) OTOKL8BF TM86B_HUMAN Decreases Expression [12]
Interleukin-22 receptor subunit alpha-1 (IL22RA1) OTGVKLBR I22R1_HUMAN Decreases Expression [12]
Sodium-dependent lysophosphatidylcholine symporter 1 (MFSD2A) OTVG1VG0 NLS1_HUMAN Decreases Expression [12]
Mixed lineage kinase domain-like protein (MLKL) OTDSLC81 MLKL_HUMAN Increases Expression [12]
Clarin-3 (CLRN3) OTZDNL65 CLRN3_HUMAN Decreases Expression [12]
Phosphatidylinositol 4-kinase type 2-beta (PI4K2B) OT0D51QP P4K2B_HUMAN Decreases Expression [12]
Serine/threonine-protein kinase BRSK1 (BRSK1) OT6N35Q0 BRSK1_HUMAN Decreases Expression [12]
Transmembrane protein 171 (TMEM171) OTJPHOWW TM171_HUMAN Increases Expression [12]
Thyroid hormone-inducible hepatic protein (THRSP) OTKYE01L THRSP_HUMAN Decreases Expression [12]
Solute carrier organic anion transporter family member 2A1 (SLCO2A1) OT3062CA SO2A1_HUMAN Increases Expression [12]
Liver-expressed antimicrobial peptide 2 (LEAP2) OTUOPIS5 LEAP2_HUMAN Decreases Expression [12]
Interferon-stimulated gene 20 kDa protein (ISG20) OTCWRJJW ISG20_HUMAN Decreases Expression [12]
GTP-binding protein Rhes (RASD2) OTETA815 RHES_HUMAN Increases Expression [12]
FXYD domain-containing ion transport regulator 5 (FXYD5) OT81DIOD FXYD5_HUMAN Increases Expression [12]
Endoplasmic reticulum resident protein 27 (ERP27) OTVMGE2H ERP27_HUMAN Decreases Expression [12]
E3 ubiquitin-protein ligase RNF125 (RNF125) OTBD1Q3X RN125_HUMAN Decreases Expression [12]
Uncharacterized protein C11orf24 (C11ORF24) OT2DOJ6E CK024_HUMAN Decreases Expression [12]
Calmodulin-like protein 4 (CALML4) OT6DD5EW CALL4_HUMAN Decreases Expression [12]
Transmembrane protein 41A (TMEM41A) OTAAULKY TM41A_HUMAN Decreases Expression [12]
SH2 domain-containing adapter protein D (SHD) OTGTHL5V SHD_HUMAN Decreases Expression [12]
Membrane-spanning 4-domains subfamily A member 10 (MS4A10) OTH3LAUX M4A10_HUMAN Decreases Expression [12]
Serine protease FAM111A (FAM111A) OTVLARLG F111A_HUMAN Decreases Expression [12]
Tribbles homolog 3 (TRIB3) OTG5OS7X TRIB3_HUMAN Decreases Expression [12]
Serine incorporator 2 (SERINC2) OTZ039U0 SERC2_HUMAN Increases Expression [12]
Iron-sulfur cluster assembly 1 homolog, mitochondrial (ISCA1) OTU230MC ISCA1_HUMAN Increases Expression [12]
Guanine nucleotide-binding protein-like 3 (GNL3) OTILGYO4 GNL3_HUMAN Increases Expression [12]
Group XIIB secretory phospholipase A2-like protein (PLA2G12B) OTY7GXA6 PG12B_HUMAN Decreases Expression [12]
Sulfiredoxin-1 (SRXN1) OTYDBO4L SRXN1_HUMAN Increases Expression [12]
Alanine--glyoxylate aminotransferase 2, mitochondrial (AGXT2) OTO6QUTM AGT2_HUMAN Decreases Expression [12]
DNA-directed RNA polymerase I subunit RPA49 (POLR1E) OTCBMKW6 RPA49_HUMAN Increases Expression [12]
Cytosolic beta-glucosidase (GBA3) OT86XWU2 GBA3_HUMAN Decreases Expression [12]
Mid1-interacting protein 1 (MID1IP1) OTFCORJM M1IP1_HUMAN Decreases Expression [12]
PI-PLC X domain-containing protein 1 (PLCXD1) OTU7KCQL PLCX1_HUMAN Decreases Expression [12]
Ethanolamine kinase 2 (ETNK2) OT5S1Z75 EKI2_HUMAN Decreases Expression [12]
Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 (SOHLH2) OTB9EM6C SOLH2_HUMAN Increases Expression [12]
H/ACA ribonucleoprotein complex subunit 1 (GAR1) OTA580RX GAR1_HUMAN Increases Expression [12]
Cingulin (CGN) OTBCQ8AQ CING_HUMAN Decreases Expression [12]
Alpha-aminoadipic semialdehyde synthase, mitochondrial (AASS) OTYCN07T AASS_HUMAN Decreases Expression [12]
Lipid transferase CIDEB (CIDEB) OT873IYM CIDEB_HUMAN Decreases Expression [12]
Transcription factor SOX-13 (SOX13) OTCIF6KC SOX13_HUMAN Decreases Expression [12]
Microtubule-associated protein RP/EB family member 3 (MAPRE3) OTSCLETV MARE3_HUMAN Increases Expression [12]
Regulating synaptic membrane exocytosis protein 2 (RIMS2) OTQASWDH RIMS2_HUMAN Decreases Expression [12]
Protein phosphatase 1 regulatory subunit 3C (PPP1R3C) OTEU05TX PPR3C_HUMAN Decreases Expression [12]
Adhesion G-protein coupled receptor G1 (ADGRG1) OTQBB8NT AGRG1_HUMAN Increases Expression [12]
Solute carrier family 22 member 7 (SLC22A7) OTKTNH1W S22A7_HUMAN Decreases Expression [12]
Golgi integral membrane protein 4 (GOLIM4) OTB5NV8A GOLI4_HUMAN Decreases Expression [13]
Long-chain fatty acid transport protein 2 (SLC27A2) OT7JEG5F S27A2_HUMAN Decreases Expression [13]
Rho guanine nucleotide exchange factor 10 (ARHGEF10) OTHJ1Y4I ARHGA_HUMAN Decreases Expression [13]
Secretory carrier-associated membrane protein 1 (SCAMP1) OTFS4IKJ SCAM1_HUMAN Increases Expression [13]
Cochlin (COCH) OTBEHD89 COCH_HUMAN Decreases Expression [13]
Mitochondrial carnitine/acylcarnitine carrier protein (SLC25A20) OT6CLFXB MCAT_HUMAN Decreases Expression [13]
NUAK family SNF1-like kinase 1 (NUAK1) OTLLHJJQ NUAK1_HUMAN Decreases Expression [13]
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2) OTITCN3Q MA1A2_HUMAN Decreases Expression [13]
E3 ubiquitin-protein ligase listerin (LTN1) OTIW2HTX LTN1_HUMAN Decreases Expression [13]
Solute carrier organic anion transporter family member 2B1 (SLCO2B1) OTERJ4VQ SO2B1_HUMAN Decreases Expression [13]
Amino acid transporter heavy chain SLC3A2 (SLC3A2) OTBR33M9 4F2_HUMAN Increases Expression [13]
RNA-binding protein RO60 (RO60) OTLGM5A8 RO60_HUMAN Decreases Expression [13]
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A) OTDRV63V GA45A_HUMAN Increases Expression [13]
ETS domain-containing protein Elk-4 (ELK4) OTVSSEOE ELK4_HUMAN Increases Expression [13]
DNA damage-inducible transcript 3 protein (DDIT3) OTI8YKKE DDIT3_HUMAN Increases Expression [13]
Serine/threonine-protein kinase SIK1 (SIK1) OT6FCHME SIK1_HUMAN Increases Expression [13]
Zinc finger protein Rlf (RLF) OTCSPZVK RLF_HUMAN Increases Expression [13]
Kelch-like ECH-associated protein 1 (KEAP1) OTFHOD0C KEAP1_HUMAN Increases Expression [13]
Src substrate cortactin (CTTN) OTJRG4ES SRC8_HUMAN Decreases Expression [13]
Protein disulfide-isomerase A5 (PDIA5) OT76ZSX5 PDIA5_HUMAN Decreases Expression [13]
Neuronal regeneration-related protein (NREP) OT2AZPKK NREP_HUMAN Decreases Expression [13]
Dual specificity protein phosphatase 5 (DUSP5) OTH96RA7 DUS5_HUMAN Increases Expression [13]
Atos homolog protein A (ATOSA) OTWFM5G0 ATOSA_HUMAN Decreases Expression [13]
Glycerol-3-phosphate acyltransferase 3 (GPAT3) OTJUGPK0 GPAT3_HUMAN Increases Expression [13]
Ribosomal protein eS27-like (RPS27L) OTZWHU0N RS27L_HUMAN Decreases Expression [13]
SH3 domain and tetratricopeptide repeat-containing protein 1 (SH3TC1) OT0HYZIU S3TC1_HUMAN Increases Expression [13]
Uncharacterized protein C4orf3 (C4ORF3) OT6TFN1O CD003_HUMAN Decreases Expression [13]
Sortilin-related receptor (SORL1) OTQ8FFNS SORL_HUMAN Decreases Expression [13]
GTP-binding protein Rit1 (RIT1) OTVNOGOH RIT1_HUMAN Increases Expression [13]
Tumor protein p53-inducible nuclear protein 1 (TP53INP1) OT2363Z9 T53I1_HUMAN Decreases Expression [13]
Protein orai-3 (ORAI3) OTUP3OH3 ORAI3_HUMAN Decreases Expression [13]
Ectonucleoside triphosphate diphosphohydrolase 7 (ENTPD7) OT3QER33 ENTP7_HUMAN Decreases Expression [13]
Oxidative stress-induced growth inhibitor 1 (OSGIN1) OT9KIVZW OSGI1_HUMAN Increases Expression [13]
Insulin-induced gene 2 protein (INSIG2) OTX4VY51 INSI2_HUMAN Decreases Expression [13]
Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (ARFGEF2) OTM3CQZT BIG2_HUMAN Increases Expression [13]
Nuclear receptor subfamily 1 group I member 2 (NR1I2) OTC5U0N5 NR1I2_HUMAN Affects Localization [32]
ATP-dependent translocase ABCB1 (ABCB1) OTEJROBO MDR1_HUMAN Increases Expression [32]
Stearoyl-CoA desaturase (SCD) OTB1073G SCD_HUMAN Increases Expression [33]
Apoptotic protease-activating factor 1 (APAF1) OTJWIVY0 APAF_HUMAN Decreases Expression [34]
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) OTA1CPBV TR10B_HUMAN Increases Expression [35]
Centrin-3 (CETN3) OTG4PL7H CETN3_HUMAN Decreases Expression [34]
Protein phosphatase 1G (PPM1G) OTLZL9CG PPM1G_HUMAN Increases Expression [34]
Baculoviral IAP repeat-containing protein 5 (BIRC5) OTILXZYL BIRC5_HUMAN Decreases Expression [17]
CASP8 and FADD-like apoptosis regulator (CFLAR) OTX14BAS CFLAR_HUMAN Decreases Expression [17]
Death effector domain-containing protein (DEDD) OTIL349E DEDD_HUMAN Increases Expression [34]
Protein phosphatase 1 regulatory subunit 15A (PPP1R15A) OTYG179K PR15A_HUMAN Increases Expression [34]
STAM-binding protein (STAMBP) OTOT2OXM STABP_HUMAN Decreases Expression [34]
Centrosomal protein 43 (CEP43) OT8TRHCF CEP43_HUMAN Decreases Expression [34]
Cytochrome b5 (CYB5A) OT6SN4RM CYB5_HUMAN Affects Expression [14]
Prothrombin (F2) OTNFSM49 THRB_HUMAN Affects Expression [14]
Myc proto-oncogene protein (MYC) OTPV5LUK MYC_HUMAN Decreases Expression [36]
Transforming growth factor beta-1 proprotein (TGFB1) OTV5XHVH TGFB1_HUMAN Decreases Expression [37]
Alpha-crystallin B chain (CRYAB) OTY4JGYU CRYAB_HUMAN Affects Expression [14]
Prelamin-A/C (LMNA) OT3SG7ZR LMNA_HUMAN Affects Expression [14]
Fibrinogen gamma chain (FGG) OT5BJSEX FIBG_HUMAN Affects Expression [14]
C-reactive protein (CRP) OT0RFT8F CRP_HUMAN Decreases Expression [38]
Serotransferrin (TF) OT41PEMS TRFE_HUMAN Affects Expression [14]
Ferritin light chain (FTL) OTYQA8A6 FRIL_HUMAN Affects Expression [14]
Annexin A1 (ANXA1) OT5OFDJC ANXA1_HUMAN Affects Expression [14]
Superoxide dismutase , mitochondrial (SOD2) OTIWXGZ9 SODM_HUMAN Decreases Expression [39]
Heat shock protein beta-1 (HSPB1) OTHFZ8ED HSPB1_HUMAN Affects Expression [14]
Plasminogen activator inhibitor 1 (SERPINE1) OTT0MPQ3 PAI1_HUMAN Decreases Expression [40]
Transcription factor AP-2-alpha (TFAP2A) OTMYT3NK AP2A_HUMAN Increases Expression [41]
Beta-casein (CSN2) OT22C0PD CASB_HUMAN Increases Expression [42]
Retinoblastoma-associated protein (RB1) OTQJUJMZ RB_HUMAN Decreases Phosphorylation [43]
ATP synthase subunit beta, mitochondrial (ATP5F1B) OTLFZUQK ATPB_HUMAN Decreases Expression [44]
Alpha-enolase (ENO1) OTB1KWJS ENOA_HUMAN Affects Expression [14]
Tropomyosin alpha-3 chain (TPM3) OT5RU5G6 TPM3_HUMAN Decreases Expression [45]
Protein disulfide-isomerase (P4HB) OTTYNYPF PDIA1_HUMAN Affects Expression [14]
Integrin alpha-IIb (ITGA2B) OT4Y17PY ITA2B_HUMAN Affects Expression [14]
Interleukin-8 (CXCL8) OTS7T5VH IL8_HUMAN Decreases Expression [46]
Hepatic triacylglycerol lipase (LIPC) OTZY5SC9 LIPC_HUMAN Increases Expression [47]
Collagen alpha-1(VI) chain (COL6A1) OTYKSCOB CO6A1_HUMAN Affects Expression [14]
Collagen alpha-2(VI) chain (COL6A2) OTQC6PPO CO6A2_HUMAN Affects Expression [14]
Cadherin-1 (CDH1) OTFJMXPM CADH1_HUMAN Increases Expression [48]
C-C motif chemokine 5 (CCL5) OTSCA5CK CCL5_HUMAN Decreases Response To Substance [49]
Beta-3 adrenergic receptor (ADRB3) OTPMG4V7 ADRB3_HUMAN Decreases Expression [50]
Nidogen-1 (NID1) OTKLBLS6 NID1_HUMAN Affects Expression [14]
Solute carrier family 2, facilitated glucose transporter member 4 (SLC2A4) OTJZG0LD GLUT4_HUMAN Increases Expression [51]
Fatty acid-binding protein, adipocyte (FABP4) OT3DKFOU FABP4_HUMAN Increases Expression [52]
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (GNB3) OTA6HYBA GBB3_HUMAN Affects Expression [14]
Neutrophil cytosol factor 2 (NCF2) OTAUW7L2 NCF2_HUMAN Decreases Expression [53]
Endothelin receptor type B (EDNRB) OTLLZV3P EDNRB_HUMAN Increases Expression [54]
Cyclin-C (CCNC) OTMVK4K4 CCNC_HUMAN Decreases Expression [34]
Tumor necrosis factor receptor superfamily member 6 (FAS) OTP9XG86 TNR6_HUMAN Increases Expression [48]
Moesin (MSN) OTZJ4J6G MOES_HUMAN Affects Expression [14]
Mitogen-activated protein kinase 3 (MAPK3) OTCYKGKO MK03_HUMAN Increases Phosphorylation [55]
Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) OT5BZ1J9 P85A_HUMAN Increases Expression [16]
Mitogen-activated protein kinase 1 (MAPK1) OTH85PI5 MK01_HUMAN Increases Phosphorylation [55]
Protein disulfide-isomerase A3 (PDIA3) OTHPQ0Q3 PDIA3_HUMAN Affects Expression [14]
Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PPP2R1A) OTYA3GB4 2AAA_HUMAN Increases Expression [34]
G1/S-specific cyclin-D2 (CCND2) OTDULQF9 CCND2_HUMAN Decreases Expression [56]
G1/S-specific cyclin-D3 (CCND3) OTNKPQ22 CCND3_HUMAN Decreases Expression [57]
Peroxiredoxin-2 (PRDX2) OTLWCY9T PRDX2_HUMAN Affects Expression [14]
T-lymphocyte activation antigen CD80 (CD80) OTJBLUQE CD80_HUMAN Decreases Expression [58]
Phosphoenolpyruvate carboxykinase, cytosolic (PCK1) OTNWEJ5Y PCKGC_HUMAN Increases Expression [59]
Myosin-9 (MYH9) OT94Z706 MYH9_HUMAN Affects Expression [14]
Tumor necrosis factor receptor superfamily member 3 (LTBR) OT2HVZGV TNR3_HUMAN Increases Expression [34]
Cyclin-dependent kinase inhibitor 1 (CDKN1A) OTQWHCZE CDN1A_HUMAN Increases Expression [34]
Neuroblastoma suppressor of tumorigenicity 1 (NBL1) OTT37U4O NBL1_HUMAN Increases Expression [34]
Cyclin-dependent kinase inhibitor 1B (CDKN1B) OTNY5LLZ CDN1B_HUMAN Increases Expression [56]
Steroidogenic acute regulatory protein, mitochondrial (STAR) OTFEZ5AI STAR_HUMAN Increases Expression [60]
CCAAT/enhancer-binding protein alpha (CEBPA) OTOM9OE4 CEBPA_HUMAN Increases Expression [61]
Acyl-coenzyme A thioesterase 2, mitochondrial (ACOT2) OTAKUO27 ACOT2_HUMAN Increases Expression [62]
Tuberin (TSC2) OT47LWI9 TSC2_HUMAN Increases Phosphorylation [63]
Death-associated protein 1 (DAP) OT5YLL7E DAP1_HUMAN Increases Expression [34]
Small ribosomal subunit protein mS29 (DAP3) OTNPEZYM RT29_HUMAN Decreases Expression [34]
Caveolin-2 (CAV2) OT1FGRQX CAV2_HUMAN Increases Expression [42]
Microsomal triglyceride transfer protein large subunit (MTTP) OTNUVSDT MTP_HUMAN Increases Expression [62]
Laminin subunit beta-2 (LAMB2) OT71OI2Y LAMB2_HUMAN Affects Expression [14]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN) OTOWDUNT PTEN_HUMAN Increases Expression [64]
GTP-binding nuclear protein Ran (RAN) OT2TER5M RAN_HUMAN Decreases Expression [34]
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (GNB1) OTLL7L74 GBB1_HUMAN Affects Expression [14]
Tropomyosin alpha-4 chain (TPM4) OTN4YLYR TPM4_HUMAN Affects Expression [14]
Bcl-2-like protein 1 (BCL2L1) OTRC5K9O B2CL1_HUMAN Increases Expression [34]
Prolow-density lipoprotein receptor-related protein 1 (LRP1) OTHTEH4G LRP1_HUMAN Increases Expression [65]
Peroxisomal bifunctional enzyme (EHHADH) OTBAAHL5 ECHP_HUMAN Increases Expression [62]
Nuclear receptor subfamily 1 group I member 3 (NR1I3) OTS3SGH7 NR1I3_HUMAN Increases Expression [62]
Peroxisomal acyl-coenzyme A oxidase 1 (ACOX1) OTM0A0DY ACOX1_HUMAN Increases Expression [47]
Mediator of RNA polymerase II transcription subunit 1 (MED1) OTOO24C4 MED1_HUMAN Affects Binding [66]
Transcription factor E2F4 (E2F4) OTB3JFH4 E2F4_HUMAN Decreases Expression [67]
Bcl-2 homologous antagonist/killer (BAK1) OTDP6ILW BAK_HUMAN Increases Expression [34]
kinase isozyme 4, mitochondrial (PDK4) OTCMHMBZ PDK4_HUMAN Increases Expression [68]
Caveolae-associated protein 1 (CAVIN1) OTFO915U CAVN1_HUMAN Affects Expression [14]
Long-chain fatty acid transport protein 1 (SLC27A1) OTK03OZN S27A1_HUMAN Decreases Expression [68]
Adiponectin receptor protein 2 (ADIPOR2) OT2HDTL8 PAQR2_HUMAN Increases Expression [69]
Ferritin, mitochondrial (FTMT) OTIUX6XG FTMT_HUMAN Affects Expression [14]
Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1B) OTDNRW37 CPT1B_HUMAN Increases Expression [70]
Bcl2-associated agonist of cell death (BAD) OT63ERYM BAD_HUMAN Increases Expression [34]
Adiponectin receptor protein 1 (ADIPOR1) OT65ZFZN PAQR1_HUMAN Affects Expression [71]
Necdin (NDN) OTYBYJ82 NECD_HUMAN Increases Expression [67]
Retinoic acid receptor responder protein 2 (RARRES2) OT1BJE8K RARR2_HUMAN Decreases Expression [72]
Serine/threonine-protein kinase PINK1, mitochondrial (PINK1) OT50NR57 PINK1_HUMAN Increases Expression [73]
COMM domain-containing protein 5 (COMMD5) OT6R7DXN COMD5_HUMAN Increases Expression [74]
Ras-related protein Rab-1B (RAB1B) OTAFCUAS RAB1B_HUMAN Increases Expression [34]
Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAM) OTR1XD9B GPAT1_HUMAN Increases Expression [62]
Chorion-specific transcription factor GCMa (GCM1) OT5CPAUT GCM1_HUMAN Increases Expression [22]
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) OTHCDQ22 PRGC1_HUMAN Increases Expression [51]
Probable ATP-dependent RNA helicase DDX41 (DDX41) OT6KEIHP DDX41_HUMAN Increases Expression [34]
Cyclin-L1 (CCNL1) OTAJSS3D CCNL1_HUMAN Decreases Expression [34]
Anaphase-promoting complex subunit 10 (ANAPC10) OTM03SME APC10_HUMAN Decreases Expression [34]
Nuclear factor of activated T-cells, cytoplasmic 2 (NFATC2) OTK5T6HZ NFAC2_HUMAN Affects Response To Substance [75]
Phosphatidate phosphatase LPIN1 (LPIN1) OTQ75KF2 LPIN1_HUMAN Increases Response To Substance [76]
------------------------------------------------------------------------------------
⏷ Show the Full List of 388 DOT(s)

References

1 ClinicalTrials.gov (NCT02475499) Incretin-based Drugs and Pancreatic Cancer
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6841).
3 Metformin/Repaglinide (PrandiMet) for type 2 diabetes. Med Lett Drugs Ther. 2009 Jun 1;51(1313):41-3.
4 Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium. Clin Pharmacol Ther. 2018 Nov;104(5):900-915.
5 Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide. Clin Pharmacokinet. 2007;46(2):93-108.
6 Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism. Br J Clin Pharmacol. 2010 Dec;70(6):870-80.
7 Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin Pharmacol Ther. 2005 Jun;77(6):468-78. doi: 10.1016/j.clpt.2005.01.018.
8 A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci. 2013 Nov;136(1):216-41.
9 Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays. Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):241-9.
10 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
11 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
12 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
13 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
14 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
15 Rosiglitazone induces the unfolded protein response, but has no significant effect on cell viability, in monocytic and vascular smooth muscle cells. Biochem Biophys Res Commun. 2010 Oct 1;400(4):689-95. doi: 10.1016/j.bbrc.2010.08.129. Epub 2010 Sep 9.
16 Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes. Biochem Biophys Res Commun. 1999 Nov;265(1):265-71. doi: 10.1006/bbrc.1999.1657.
17 All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells. Eur J Haematol. 2009 Sep;83(3):191-202. doi: 10.1111/j.1600-0609.2009.01277.x. Epub 2009 May 8.
18 ATP-binding cassette transporters in human heart failure. Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377(3):231-43.
19 Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. Clin Pharmacol Ther. 2005 May;77(5):404-14.
20 Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. Br J Clin Pharmacol. 1999 Sep;48(3):424-32.
21 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
22 Regulation of the placental BCRP transporter by PPAR gamma. J Biochem Mol Toxicol. 2017 May;31(5):10.1002/jbt.21880. doi: 10.1002/jbt.21880. Epub 2016 Nov 23.
23 Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity. J Mol Endocrinol. 2004 Apr;32(2):425-36.
24 Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation. Biochem Biophys Res Commun. 2004 Oct 22;323(3):782-8.
25 Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. Mol Endocrinol. 2005 Oct;19(10):2502-16.
26 Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes. Biochem Pharmacol. 2006 Feb 28;71(5):605-14.
27 Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes. J Clin Endocrinol Metab. 2007 Feb;92(2):720-4.
28 Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Mol Pharmacol. 2007 Sep;72(3):674-85.
29 Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Aug;37(8):739-45.
30 Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci. 2010 Dec; 118(2):485-500.
31 PPARgama activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol. 2014 Mar;253:16-27.
32 A comprehensive evaluation of anti-diabetic drugs on nuclear receptor PXR platform. Toxicol In Vitro. 2019 Oct;60:347-358.
33 Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes. 2005 May;54(5):1379-84. doi: 10.2337/diabetes.54.5.1379.
34 Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202. Endocr Relat Cancer. 2007 Jun;14(2):305-15. doi: 10.1677/ERC-06-0003.
35 Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med. 2008 Mar 15;44(6):1055-68. doi: 10.1016/j.freeradbiomed.2007.12.001. Epub 2007 Dec 8.
36 [Proliferation and apoptosis effect of rosiglitazone on human ovarian cancer cell line SKOV3]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Mar;40(2):217-22.
37 [Effect of Rosiglitazone on the proliferation and the production of transforming growth factor-beta 1 in cultured human Tenon' s capsule fibroblasts]. Zhonghua Yan Ke Za Zhi. 2008 May;44(5):413-7.
38 Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1804-9. doi: 10.1161/01.ATV.0000176192.16951.9a. Epub 2005 Jul 7.
39 Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. Antioxid Redox Signal. 2014 May 20;20(15):2326-46. doi: 10.1089/ars.2013.5295. Epub 2013 Nov 14.
40 Effects of fibrate compounds on expression of plasminogen activator inhibitor-1 by cultured endothelial cells. Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1577-81. doi: 10.1161/01.atv.19.6.1577.
41 VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity. Sci Rep. 2018 Oct 31;8(1):16092. doi: 10.1038/s41598-018-34259-0.
42 Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells. Biochem Pharmacol. 2006 Aug 28;72(5):530-40. doi: 10.1016/j.bcp.2006.05.009. Epub 2006 Jun 27.
43 Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells. Exp Cell Res. 2011 Jun 10;317(10):1397-410. doi: 10.1016/j.yexcr.2011.02.014. Epub 2011 Mar 3.
44 Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor co-activator-1 protein. Br J Pharmacol. 2010 Oct;161(4):771-81. doi: 10.1111/j.1476-5381.2010.00900.x.
45 Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia. Mol Pharmacol. 2009 Jul;76(1):183-91. doi: 10.1124/mol.109.056028. Epub 2009 Apr 15.
46 Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem. 2001 Aug 17;276(33):31059-66. doi: 10.1074/jbc.M104141200. Epub 2001 Jun 7.
47 In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist. PPAR Res. 2012;2012:546548. doi: 10.1155/2012/546548. Epub 2012 Oct 22.
48 Regulatory role of KEAP1 and NRF2 in PPAR expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic Biol Med. 2012 Aug 15;53(4):758-68. doi: 10.1016/j.freeradbiomed.2012.05.041. Epub 2012 Jun 7.
49 Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma. Hypertension. 2008 Feb;51(2):259-66. doi: 10.1161/HYPERTENSIONAHA.107.099028. Epub 2007 Dec 24.
50 Impact of rosiglitazone on the expression of beta3-AR in the stable cell lines expressed beta3-AR gene. Clin Chem Lab Med. 2007;45(11):1511-6. doi: 10.1515/CCLM.2007.315.
51 Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. Diabetologia. 2005 Jun;48(6):1173-9. doi: 10.1007/s00125-005-1741-3. Epub 2005 Apr 30.
52 Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands. J Pharmacol Exp Ther. 2004 Nov;311(2):467-75. doi: 10.1124/jpet.104.068254. Epub 2004 Jul 23.
53 Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. Am J Pathol. 2007 Feb;170(2):722-32. doi: 10.2353/ajpath.2007.060651.
54 Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor. Hypertension. 2010 Jul;56(1):129-35. doi: 10.1161/HYPERTENSIONAHA.110.150375. Epub 2010 Jun 1.
55 Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals. Mol Cancer Ther. 2009 Jan;8(1):110-8. doi: 10.1158/1535-7163.MCT-08-0719.
56 Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells. Basic Clin Pharmacol Toxicol. 2010 Jun;106(6):523-30. doi: 10.1111/j.1742-7843.2010.00539.x. Epub 2010 Feb 22.
57 Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism. Diabetologia. 2005 Mar;48(3):586-94. doi: 10.1007/s00125-005-1672-z. Epub 2005 Feb 24.
58 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development. J Immunol. 2007 May 15;178(10):6130-9. doi: 10.4049/jimmunol.178.10.6130.
59 Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie. 2003 Dec;85(12):1257-64. doi: 10.1016/j.biochi.2003.10.016.
60 Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod Biol Endocrinol. 2009 Dec 9;7:147. doi: 10.1186/1477-7827-7-147.
61 Effects of Perinatal Exposure to Dibutyltin Chloride on Fat and Glucose Metabolism in Mice, and Molecular Mechanisms, in Vitro. Environ Health Perspect. 2018 May 21;126(5):057006. doi: 10.1289/EHP3030. eCollection 2018 May.
62 Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. Toxicol Appl Pharmacol. 2022 May 1;442:115991. doi: 10.1016/j.taap.2022.115991. Epub 2022 Mar 23.
63 Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2. PPAR Res. 2007;2007:29632. doi: 10.1155/2007/29632.
64 PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation. Biochem Biophys Res Commun. 2003 Apr 11;303(3):782-7. doi: 10.1016/s0006-291x(03)00418-2.
65 The effect of rosiglitazone on LRP1 expression and amyloid uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment. Int J Neuropsychopharmacol. 2012 Feb;15(1):135-42. doi: 10.1017/S1461145711001611. Epub 2011 Nov 1.
66 Selective Tissue Distribution Mediates Tissue-Dependent PPAR Activation and Insulin Sensitization by INT131, a Selective PPAR Modulator. Front Pharmacol. 2017 May 30;8:317. doi: 10.3389/fphar.2017.00317. eCollection 2017.
67 Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue. Diabetes. 2006 Mar;55(3):640-50. doi: 10.2337/diabetes.55.03.06.db05-1015.
68 The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia. 2005 Jan;48(1):83-95. doi: 10.1007/s00125-004-1619-9. Epub 2004 Dec 24.
69 Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Diabetologia. 2006 Jun;49(6):1303-10. doi: 10.1007/s00125-006-0228-1. Epub 2006 Apr 12.
70 Rosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin Resistance. Patholog Res Int. 2011 Apr 12;2011:736425. doi: 10.4061/2011/736425.
71 Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia. 2005 Aug;48(8):1585-9. doi: 10.1007/s00125-005-1835-y. Epub 2005 Jul 1.
72 Bisphenol A and its derivatives decrease expression of chemerin, which reverses its stimulatory action in ovarian cancer cells. Toxicol Lett. 2018 Jul;291:61-69. doi: 10.1016/j.toxlet.2018.04.004. Epub 2018 Apr 10.
73 PPAR- activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction. Toxicol Lett. 2016 Oct 17;260:8-17. doi: 10.1016/j.toxlet.2016.08.016. Epub 2016 Aug 21.
74 Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression. Oncol Rep. 2008 Nov;20(5):1093-7.
75 Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. Diabetes Care. 2010 Oct;33(10):2250-3. doi: 10.2337/dc10-0452. Epub 2010 Jul 13.
76 LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. Mol Genet Metab. 2008 Sep-Oct;95(1-2):96-100. doi: 10.1016/j.ymgme.2008.06.011. Epub 2008 Aug 9.